COMPARISON OF THE VASOCONSTRICTOR RESPONSES INDUCED BY ENDOTHELIN AND PHORBOL 12,13-DIBUTYRATE IN BOVINE CEREBRAL-ARTERIES

被引:21
作者
FERRER, M
ENCABO, A
MARIN, J
PEIRO, C
REDONDO, J
DESAGARRA, MR
BALFAGON, G
机构
[1] UNIV AUTONOMA MADRID,FAC MED,DEPT FISIOL,C-ARZOBISPO MORCILLO 4,E-28029 MADRID,SPAIN
[2] UNIV AUTONOMA MADRID,FAC MED,DEPT FARMACOL & TERAPEUT,MADRID 34,SPAIN
[3] UNIV AUTONOMA MADRID,FAC MED,DEPT BIOQUIM,MADRID 34,SPAIN
关键词
CEREBRAL ARTERY; PHORBOL 12,13-DIBUTYRATE; CONTRACTILE RESPONSE; ELECTRICAL STIMULATION; NIFEDIPINE; ENDOTHELIN-1; PROTEIN KINASE-C; NORADRENALINE RELEASE;
D O I
10.1016/0006-8993(92)90390-U
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The vascular effects of endothelin-1 (ET-1) were compared with those elicited by phorbol 12,13-dibutyrate (PDB), an activator of the protein kinase C (PKC), to analyze the involvement of this enzyme on ET-1 responses. PDB and ET-1 caused slow-developing contractions (sustained and transient, respectively), which were reduced by the PKC inhibitor, staurosporine (1 and 10 nM). Only the contractile effects evoked by ET-1 were reduced in Ca-free medium and by the Ca channel antagonist, nifedipine (1 muM), and increased by the Ca channel agonist, BAY K 8644 (10 nM). PDB (10 and 30 nM) preincubation reduced the vasoconstriction elicited by 5-hydroxytryptamine (5-HT; 0.01, 0.1 and 1 muM) in a way dependent on phorbol concentration and preincubation time, whereas ET-1 (1 nM) increased the contractile response to 5-HT (0.1 muM). Furthermore, PDB (0.1 muM) also reduced the responses elicited by ET-1 (30 muM) and vice versa. ET-1 (0.1 muM) induced transient translocation of PKC activity from the cytosol to the membrane, which was less than that produced by PDB (0.1 muM). Electrical stimulation induced [H-3]noradrenaline (NA) release, which was increased by PDB (10 and 100 nM) and not affected by ET-1 (10 nM). These results indicate: (1) the responses induced by PDB and ET-1 were independent and dependent on extracellular Ca, respectively; (2) PKC is involved in NA release and 5-HT responses, but mainly in desensitization of these responses, and (3) PKC is activated by ET-1 and is implicated in vascular actions of ET-1, but other mechanisms, such as the activation of ET-1 receptors and opening of dihydropyridine-sensitive Ca channels also appear to be involved.
引用
收藏
页码:186 / 196
页数:11
相关论文
共 55 条
  • [1] ABDELLATIF AA, 1986, PHARMACOL REV, V38, P227
  • [2] MYOSIN LIGHT CHAIN AND CALDESMON PHOSPHORYLATION IN ARTERIAL MUSCLE STIMULATED WITH ENDOTHELIN-1
    ADAM, LP
    MILIO, L
    BRENGLE, B
    HATHAWAY, DR
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1990, 22 (09) : 1017 - 1023
  • [3] CEREBRAL ARTERIAL SPASM .5. INVITRO CONTRACTILE ACTIVITY OF VASOACTIVE AGENTS INCLUDING HUMAN CSF ON HUMAN BASILAR AND ANTERIOR CEREBRAL-ARTERIES
    ALLEN, GS
    GROSS, CJ
    FRENCH, LA
    CHOU, SN
    [J]. JOURNAL OF NEUROSURGERY, 1976, 44 (05) : 594 - 600
  • [4] ENHANCEMENT OF NORADRENALINE RELEASE BY 12-O-TETRADECANOYL PHORBOL-13-ACETATE, AN ACTIVATOR OF PROTEIN-KINASE-C
    ALLGAIER, C
    VONKUGELGEN, O
    HERTTING, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 129 (03) : 389 - 392
  • [5] COMPARATIVE EFFECTS OF ENDOTHELIN AND PHORBOL 12-13 DIBUTYRATE IN RAT AORTA
    AUGUET, M
    DELAFLOTTE, S
    CHABRIER, PE
    BRAQUET, P
    [J]. LIFE SCIENCES, 1989, 45 (21) : 2051 - 2059
  • [6] EFFECT OF PHORBOL ESTERS ON NORADRENALINE RELEASE FROM CEREBRAL-ARTERIES
    BALFAGON, G
    DESAGARRA, MR
    BARRUS, MT
    ARRIVAS, S
    CAPILLA, MI
    MARIN, J
    [J]. BRAIN RESEARCH, 1989, 477 (1-2) : 196 - 201
  • [7] SUBSTANCE-P STIMULATES TRANSLOCATION OF PROTEIN KINASE-C IN BRAIN MICROVESSELS
    CATALAN, RE
    MARTINEZ, AM
    ARAGONES, MD
    FERNANDEZ, I
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 164 (02) : 595 - 600
  • [8] CONSIGNY PM, 1989, AM J PHYSIOL, V257, pH1174
  • [9] ENDOTHELIN-1 INCREASES ARTERIAL SENSITIVITY TO 5-HYDROXYTRYPTAMINE
    CONSIGNY, PM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 186 (2-3) : 239 - 245
  • [10] DEAGUILERA EM, 1990, BRIT J PHARMACOL, V99, P439